Corundum Systems Biology
Tokyo, Tokyocsb.co.jp
Overview
Corundum Systems Biology is a venture capital investment firm based in Tokyo, Japan. The firm seeks to invest in healthcare start-ups related to the microbiome. They address the fundamental challenges of healthy longevity through a 'systems' approach to funding scientific research. By looking at the interaction of the body's ecosystems to understand the underlying causes of disease, it supports the development of targeted interventions to delay or prevent the onset of disease. CSB provides access to funding, resources, and mentorship to help researchers and entrepreneurs bring solutions to commercialization.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sequential | Mar 2026 | Early Funding | Lead |
| Holobiome | Oct 2024 | Seed | Co-investor |
| Freya Biosciences | Dec 2023 | Series A | Co-investor |
| Sequential | May 2023 | Seed | Lead |
| Concerto Biosciences | Nov 2022 | Series A | Co-investor |
Key People
Yasushi Yamamoto
Founder Executive Director
Henry Haiser
Operating Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.